ADLI — American Medical Technologies Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for American Medical Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2003 December 31st | 2004 December 31st | 2005 December 31st | C2006 December 31st | 2007 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10KSB | 10KSB | 10KSB | 10KSB | 10KSB |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.218 | 2.03 | 1.27 | 0.25 | 0.02 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.21 | 0.21 | 0.1 | 0.273 | 0.272 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.48 | 3.28 | 2.19 | 1.48 | 0.899 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.39 | 1.32 | 1.27 | 0.109 | 0.089 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 8.05 | 4.61 | 3.46 | 2.06 | 1.84 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.5 | 1.43 | 1.94 | 2.26 | 1.85 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4.18 | 2.11 | 2.54 | 2.92 | 2.35 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 3.87 | 2.5 | 0.919 | -0.854 | -0.511 |
| Total Liabilities & Shareholders' Equity | 8.05 | 4.61 | 3.46 | 2.06 | 1.84 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |